购物车
全部删除
您的购物车当前为空
ST-899 是一种创新的血小板活化因子 (PAF) 受体拮抗剂。它能够显著降低内毒素 (LPS) 诱导的小鼠休克死亡率,并有效抑制 LPS 诱导的血清肿瘤坏死因子 (TNF) 水平上升,但不影响白细胞介素-6 (IL-6) 的水平。其机制在于阻断 PAF 和 TNF 之间的正反馈循环,进而减轻炎症反应。ST-899 可用于研究脓毒症休克等与炎症相关的疾病。

ST-899 是一种创新的血小板活化因子 (PAF) 受体拮抗剂。它能够显著降低内毒素 (LPS) 诱导的小鼠休克死亡率,并有效抑制 LPS 诱导的血清肿瘤坏死因子 (TNF) 水平上升,但不影响白细胞介素-6 (IL-6) 的水平。其机制在于阻断 PAF 和 TNF 之间的正反馈循环,进而减轻炎症反应。ST-899 可用于研究脓毒症休克等与炎症相关的疾病。
| 规格 | 价格 | 库存 | 数量 |
|---|---|---|---|
| 10 mg | 待询 | 10-14周 | |
| 50 mg | 待询 | 10-14周 |
ST-899 相关产品
| 产品描述 | ST-899 is an innovative platelet-activating factor (PAF) receptor antagonist. It significantly reduces the mortality rate in mice experiencing shock induced by endotoxins (LPS). The compound markedly inhibits the LPS-induced increase in serum tumor necrosis factor (TNF) levels while leaving interleukin-6 (IL-6) unaffected. The mechanism by which ST-899 operates involves disrupting the positive feedback loop between PAF and TNF, thereby mitigating inflammatory responses. ST-899 is applicable for studies related to inflammatory diseases such as septic shock. |
| 分子量 | 518.83 |
| 分子式 | C22H29BrClNO6 |
| CAS No. | 143484-41-7 |
| 存储 | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. |
评论内容